Open Access. Powered by Scholars. Published by Universities.®

Oncology Commons

Open Access. Powered by Scholars. Published by Universities.®

Arts and Humanities

2013

Lung Neoplasms

Articles 1 - 2 of 2

Full-Text Articles in Oncology

Oncolog, Volume 58, Number 05, May 2013, Jill Deisigne, Bryan Tutt May 2013

Oncolog, Volume 58, Number 05, May 2013, Jill Deisigne, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

  • Robotic Surgery Makes Tissue Harvest for Breast Reconstruction Less Invasive: A new minimally invasive robotic procedure enables surgeons to harvest latissimus dorsi muscle flaps for breast reconstruction with less scarring and discomfort than traditional techniques
  • Diagnosis and Treatment of Invasive Fungal Infections in patients with Hematological Malingnancies: Invasive fungal infections are important causes of morbidity and death for patients with hematological malignancies. Although much progress has been made in the management of opportunistic fungal infections, their diagnosis and treatment remain a challenge
  • INBRIEF: Beta-Blocker Use Associated With Higher Survival Rates in Lung Cancer Patients Receiving Radiation Therapy/ Selumetinib Shows Promise …


Oncolog, Volume 58, Number 03, March 2013, Sarah Bronson, Zach Bohannan, Bryan Tutt Mar 2013

Oncolog, Volume 58, Number 03, March 2013, Sarah Bronson, Zach Bohannan, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

  • Advances in Pulmonary Medicine Facilitate Cancer Diagnosis, Treatment: The lungs present unique challenges in cancer diagnosis and treatment-navigating a maze of bronchi to find and sample tissue that will lead to an accurate diagnosis of lung cancer, for example, or deciding whether to proceed with treatment for cancer in the presence of concomitant lung disease
  • New Drugs Increase Treatment Options for Patients with Imatinib-Resistant Chronic Myeloid Leukemia: In the past year, several new targeted drugs have been approved as second-line treatments for imatinib-resistant chronic myeloid leukemia (CML). These drugs include the second-generation tyrosine kinase inhibitor bosutinib and the third-generation tyrosine …